Axplora

Hochstrass-Süd 7
83064 Raubling
Germany

Contact WebSite

Axplora is a trusted manufacturing partner to over 900 of the world’s leading pharmaceutical and biotech companies, formed from the integration of PharmaZell, Farmabios, and Novasep CDMO—three industry leaders with decades of experience in pharmaceutical manufacturing. Axplora delivers high-quality, reliable, and sustainable solutions across the pharmaceutical value chain.

With deep capabilities in complex chemistry and industrial manufacturing combined with an agile, explorer’s mindset, Axplora supports pharmaceutical and biotech companies in developing and producing life-changing therapies. PharmaZell and Farmabios are renowned for their expertise in active pharmaceutical ingredients (APIs), highly potent compounds, and regulatory excellence, while Novasep CDMO is a leader in small molecule and antibody-drug conjugates (ADCs) manufacturing while being a pioneer in purification technologies.

Axplora operates 9 API manufacturing sites across Europe and India, providing multi-site capacity to partners worldwide.

Article

Axplora Announces €35 Million Expansion at Farmabios
01.07.2025 • NewsPharma

Axplora Announces €35 Million Expansion at Farmabios

Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.

Axplora Expands Capabilities at Le Mans Site
10.03.2025 • News

Axplora Expands Capabilities at Le Mans Site

Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).

Expert Statement: Martin Meeson, Axplora
02.09.2024 • TopicsChemistry

Expert Statement: Martin Meeson, Axplora

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy
10.10.2023 • News

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy

Farmabios, a company of the Axplora group founded in 2022, has received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for the first line of its new production unit at Gropello Cairoli, Italy, expanding its large scale manufacturing capabilities for high potent active pharmaceutical ingredients (HPAPIs) and steroids.

Axplora Aims to Make Pharmaceutical Supply Chains More Stable
22.02.2023 • TopicsInnovation

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.

Expert Statement: Jean-Baptiste Guillermin, Axplora
26.09.2022 • TopicsInnovation

Expert Statement: Jean-Baptiste Guillermin, Axplora

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.